Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

by · The Markets Daily

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 41,927 shares, a decline of 19.0% from the November 30th total of 51,761 shares. Currently, 3.3% of the shares of the company are short sold. Based on an average daily volume of 11,248 shares, the days-to-cover ratio is currently 3.7 days. Based on an average daily volume of 11,248 shares, the days-to-cover ratio is currently 3.7 days. Currently, 3.3% of the shares of the company are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Get Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Stock Up 8.8%

NASDAQ RKDA traded up $0.16 during trading hours on Wednesday, hitting $1.98. 51,943 shares of the stock were exchanged, compared to its average volume of 144,243. The company has a market cap of $2.71 million, a price-to-earnings ratio of 0.78 and a beta of 0.48. Arcadia Biosciences has a 12-month low of $1.76 and a 12-month high of $6.71. The stock has a 50-day moving average of $3.59 and a 200 day moving average of $3.95.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $1.16. The company had revenue of $1.30 million for the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative return on equity of 8.80% and a negative net margin of 97.97%.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Further Reading